BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1414496)

  • 21. Familial resemblance of bone mineralization, calcium intake, and physical activity in early-adolescent daughters, their mothers, and maternal grandmothers.
    Runyan SM; Stadler DD; Bainbridge CN; Miller SC; Moyer-Mileur LJ
    J Am Diet Assoc; 2003 Oct; 103(10):1320-5. PubMed ID: 14520251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heritable and life-style determinants of bone mineral density.
    Krall EA; Dawson-Hughes B
    J Bone Miner Res; 1993 Jan; 8(1):1-9. PubMed ID: 8427042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced bone mass in daughters of women with osteoporosis.
    Seeman E; Hopper JL; Bach LA; Cooper ME; Parkinson E; McKay J; Jerums G
    N Engl J Med; 1989 Mar; 320(9):554-8. PubMed ID: 2915666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial resemblance of radial bone mass between premenopausal mothers and their college-age daughters.
    Tylavsky FA; Bortz AD; Hancock RL; Anderson JJ
    Calcif Tissue Int; 1989 Nov; 45(5):265-72. PubMed ID: 2509013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
    Ravn P; Fledelius C; Rosenquist C; Overgaard K; Christiansen C
    Bone; 1996 Sep; 19(3):291-8. PubMed ID: 8873970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family resemblance of bone turnover rate in mothers and daughters--the MODAM study.
    Nagy H; Chapurlat R; Sornay-Rendu E; Boutroy S; Szulc P
    Osteoporos Int; 2015 Mar; 26(3):921-30. PubMed ID: 25524020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
    Overgaard K; Hansen MA; Dirksen KL; Christiansen C
    Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women.
    Hansen MA
    Osteoporos Int; 1994 May; 4(3):123-8. PubMed ID: 8069050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
    Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
    Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fracture rate, pre- and postmenopausal bone mass and early and late postmenopausal bone loss are not associated with vitamin D receptor genotype in a high-endemic area of osteoporosis.
    Berg JP; Falch JA; Haug E
    Eur J Endocrinol; 1996 Jul; 135(1):96-100. PubMed ID: 8765980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women.
    Vestergaard P; Hermann AP; Gram J; Jensen LB; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck Nielsen H; Pors Nielsen S; Charles P; Mosekilde L
    Maturitas; 2001 Dec; 40(3):211-20. PubMed ID: 11731182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single measurement of biochemical markers of bone turnover has limited utility in the individual person.
    Beck-Jensen JE; Kollerup G; Sørensen HA; Pors Nielsen S; Sørensen OH
    Scand J Clin Lab Invest; 1997 Jul; 57(4):351-9. PubMed ID: 9249882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone metabolism in premenopausal women with nontoxic goiter and reduced serum thyrotropin levels.
    Faber J; Overgaard K; Jarløv AE; Christiansen C
    Thyroidology; 1994 Apr; 6(1):27-32. PubMed ID: 7536445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
    Hansen MA; Overgaard K; Riis BJ; Christiansen C
    BMJ; 1991 Oct; 303(6808):961-4. PubMed ID: 1954420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial differences in pre- and postmenopausal bone homeostasis: association with bone density.
    Meier DE; Luckey MM; Wallenstein S; Lapinski RH; Catherwood B
    J Bone Miner Res; 1992 Oct; 7(10):1181-9. PubMed ID: 1456086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of forearm bone density in premenopausal women: a study in one general practice.
    Cox ML; Khan SA; Gau DW; Cox SA; Hodkinson HM
    Br J Gen Pract; 1991 May; 41(346):194-6. PubMed ID: 1878269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic markers for the early diagnosis of postmenopausal osteoporosis.
    Isaia G; Mussetta M; Di Stefano M; Sciolla A; Triolo S; Molinatti GM
    J Endocrinol Invest; 1994 Nov; 17(10):771-4. PubMed ID: 7699209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for an effect of lactase deficiency on bone mass in pre- or postmenopausal women.
    Slemenda CW; Christian JC; Hui S; Fitzgerald J; Johnston CC
    J Bone Miner Res; 1991 Dec; 6(12):1367-71. PubMed ID: 1792946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new fluoride preparation for the prevention of postmenopausal osteoporosis: calcium monofluorophosphate.
    Affinito P; Di Carlo C; Primizia M; Petrillo G; Napolitano V; Tremolaterra F; Nappi C
    Gynecol Endocrinol; 1993 Sep; 7(3):201-5. PubMed ID: 8291458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.